3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Drug News -

Impotence drugs linked to eye damage risk - study

Drug NewsJan 17, 06

Impotence drugs such as Viagra and Cialis can increase the risk of eye damage in men who have a history of heart disease or high blood pressure, researchers said on Tuesday.

In a small study, scientists at the University of Alabama in Birmingham found that men who had suffered a heart attack were 10 times more likely to have optic nerve damage if they had been taking leading anti-impotence pills.

“For patients with a history of myocardial infarction (heart attack), we did observe a strong and statistically significant association suggestive of a link between the use of Viagra and/or Cialis and an increased risk of NAION,” Dr Gerald McGwin, who headed the study, said in a report in the British Journal of Ophthalmology.

Non-arteritic anterior ischaemic optic neuropathy (NAION) is the most common cause of acute optic nerve disease in people over 50 years old. It can cause permanent loss of vision in one or both eyes.

Viagra, made by Pfizer Inc and Eli Lilly and Co’s Cialis, are leading impotence treatments.

McGwin and his team questioned 76 men, half of whom suffered from NAION, who were treated at a specialist eye clinic in the United States, about their smoking and drinking habits and use of anti-impotence pills.

The researchers found that men who had had a heart attack were 10 times more likely to have optic nerve damage if they had taken the anti-impotence drugs.

Tens of millions of men have used Viagra and Cialis since the treatments were launched.

In May, the Food and Drug Administration (FDA) in the United States said it had received more than 40 reports of NAION involving impotence drugs but had not determined whether the treatments were responsible.

Pfizer said a review of 103 Viagra clinical trials involving more than 13,000 patients found no reports of NAION. But the company has changed the label on Viagra to note reports of NAION.

“The labels have been updated,” said a spokesman.

Eli Lilly has also changed its labels on Cialis. No one from the company was immediately available to comment on the new research.

McGwin and his team said patients with heart disease or high blood pressure should be warned about the elevated risk of NAION when taking anti-impotence pills.

“Though NAION is a rare condition, the large number of men using Viagra or Cialis suggests that, should an association truly exist, the incidence of NAION could rise dramatically,” McGwin added.



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  New biomarkers may influence drug design and alternative treatments of cancer, study shows
  UGA ecologist finds another cause of antibiotic resistance
  New drug for neuroblastoma shows promise in phase I study
  Baclofen shows promise in patients with alcohol-induced liver disease
  Findings point to an ‘off switch’ for drug resistance in cancer
  Stopping statins may benefit terminally ill patients
  Cholesterol drug users may use pills as a license to overeat
  Pfizer lung cancer drug beats chemo for previously untreated patients
  Mass. General study identifies path to safer drugs for heart disease, cancer
  Gates Foundation awards Notre Dame $23 million for malaria, dengue studies
  Cancer drug protects against diabetes
  Malaria drug target raises hopes for new treatments

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site